11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Abstract 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is an intracellular amplifier of glucocorticoid action. By converting intrinsically inert glucocorticoids (cortisone, 11-dehydrocorticosterone) into their active forms (cortisol, corticosterone), 11β-HSD1 increases glucocorticoid access to receptors. Glucocorticoid hormones modulate diverse physiological processes, linking circadian rhythms to food seeking, motivational and cognitive behaviours, as well as intermediary metabolism and immune responses. They are a key component of pathways that buffer the organism against stressful challenges. Here we review the part played in these processes by 11β-HSD1, and discuss the promise of inhibitors of 11β-HSD1 in alleviating disorders associated with cumulative stress..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2007 |
|---|---|
| Erschienen: |
2007 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Neurochemical research - 33(2007), 4 vom: 25. Okt., Seite 624-636 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chapman, Karen E. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
| doi: |
10.1007/s11064-007-9504-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR016242297 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR016242297 | ||
| 003 | DE-627 | ||
| 005 | 20230519161509.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11064-007-9504-9 |2 doi | |
| 035 | |a (DE-627)SPR016242297 | ||
| 035 | |a (SPR)s11064-007-9504-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.90 |2 bkl | ||
| 100 | 1 | |a Chapman, Karen E. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is an intracellular amplifier of glucocorticoid action. By converting intrinsically inert glucocorticoids (cortisone, 11-dehydrocorticosterone) into their active forms (cortisol, corticosterone), 11β-HSD1 increases glucocorticoid access to receptors. Glucocorticoid hormones modulate diverse physiological processes, linking circadian rhythms to food seeking, motivational and cognitive behaviours, as well as intermediary metabolism and immune responses. They are a key component of pathways that buffer the organism against stressful challenges. Here we review the part played in these processes by 11β-HSD1, and discuss the promise of inhibitors of 11β-HSD1 in alleviating disorders associated with cumulative stress. | ||
| 650 | 4 | |a Steroid metabolism |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Glucocorticoid |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a 11β-HSD1 |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Seckl, Jonathan R. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurochemical research |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1976 |g 33(2007), 4 vom: 25. Okt., Seite 624-636 |w (DE-627)SPR016233697 |w (DE-600)2018503-0 |x 1573-6903 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2007 |g number:4 |g day:25 |g month:10 |g pages:624-636 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11064-007-9504-9 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.90 |q ASE |
| 951 | |a AR | ||
| 952 | |d 33 |j 2007 |e 4 |b 25 |c 10 |h 624-636 | ||